Showing results (61-70 of 181) with videos related to

Sort By:
Pageof 19
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 10, 2003
Tuberous sclerosis-associated neoplasms express activated p42/44 mitogen-activated protein (MAP) kinase, and inhibition of MAP kinase signaling results in decreased in vivo tumor growthBaskaran Govindarajan, Melissa C Mizesko, Mark Steven Miller, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 6, 2007
A pharmacogenomic study of docetaxel and gemcitabine for the initial treatment of advanced non-small cell lung cancerW Jeffrey Petty, Sommer N Knight, Libyadda Mosley, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 6, 2005
An expression signature for p53 status in human breast cancer predicts mutation status, transcriptional effects, and patient survivalLance D Miller, Johanna Smeds, Joshy George, et al.
Annals of Surgical Oncology|July 25, 2020
Clinical Implications of Genetic Signatures in Appendiceal Cancer Patients with Incomplete Cytoreduction/HIPECOmeed Moaven, Jing Su, Guangxu Jin, et al.
Molecular Carcinogenesis|May 3, 2006
Strain-specific induction of murine lung tumors following in utero exposure to 3-methylcholanthreneJamie E Jennings-Gee, Joseph E Moore, Mian Xu, et al.
Cancer Research|July 20, 2006
Gene expression preferentially regulated by tamoxifen in breast cancer cells and correlations with clinical outcomeJonna Frasor, Edmund C Chang, Barry Komm, et al.
Journal of the American College of Surgeons|January 30, 2016
Prognostic Molecular Subtypes of Low-Grade Cancer of the AppendixEdward A Levine, Konstantinos I Votanopoulos, Shadi A Qasem, et al.
Cancer Prevention Research (Philadelphia, Pa.)|December 11, 2019
Combination of Erlotinib and Naproxen Employing Pulsatile or Intermittent Dosing Profoundly Inhibits Urinary Bladder CancersAltaf Mohammed, Mark Steven Miller, Ronald A Lubet, et al.
Carcinogenesis|November 10, 2022
Inflammation as a chemoprevention target in asbestos-induced malignant mesotheliomaYuwaraj Kadariya, Eleonora Sementino, Ujjawal Shrestha, et al.
Pageof 19